JW Pharmaceutical: all 77 studies
Page 1 of 1. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic Syndrome: An Observational StudyRecruitingNCT07523971
- To Evaluate the Safety, Pharmacokinetic and Pharmacodynamics of JW0061 in Healthy VolunteersRecruitingNCT07514780Phase 1
- Glycemic Variability of Combination Therapies in T2DMRecruitingNCT07442006Phase 4
- to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and MenorrhagiaRecruitingNCT07378098Phase 3
- To Evaluate the Safety/Tolerability and Pharmacokinetic Characteristics in Healthy VolunteersRecruitingNCT06703710Phase 1
- Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and DyslipidemiaRecruitingNCT06643130Phase 3
- Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic DermatitisCompletedNCT05117060Phase 2Results posted
- Trial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic UrticariaCompletedNCT04853992Phase 2Results posted
- Efficacy and Safety Study of Pitavastatin Compared to atoRvastatin in Type 2 dIabeTes Mellitus With HypercholesterolemiaCompletedNCT00889226Phase 4Results posted
- Efficacy and Safety of Pitavastatin/Ezetimibe After Switching From Statin Monotherapy to Pitavastatin/Ezetimibe in Patients With HypercholesterolemiaCompletedNCT07445542
- Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated TriglyceridesActive, not recruitingNCT07442630Phase 4
- Efficacy and Safety of Livalozet® in Hypercholesterolemic Patients With and Without DiabetesCompletedNCT07382778
- To Evaluate the Safety and Pharmacokinetic Characteristics in Healthy VolunteersCompletedNCT07374406Phase 1
- To Evaluate the Mass Balance Recovery, Metabolite Profile and Metabolite Identification in Healthy Male SubjectsCompletedNCT07036458Phase 1
- Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0108+C2407 in Patients With DyslipidemiaCompletedNCT06955104Phase 3
- To Evaluate the Safety and PK Characteristics in Healthy Volunteers-JW24107CompletedNCT06816719Phase 1
- To Evaluate the Safety and PK Characteristics After Co-administration of JW0104 and C2402 and Administration of JW0105CompletedNCT06754943Phase 1
- PK,PD and DDI of Epaminurad and C2406 in Healthy VolunteersCompletedNCT06665425Phase 1
- PK,PD and DDI of Epaminurad and Naproxen in Healthy VolunteersCompletedNCT06435442Phase 1
- To Evaluate the Safety and Pharmacokinetic Interactions in Healthy VolunteersCompletedNCT06378684Phase 1
- To Evaluate the Pharmacokinetic Characteristics and Safety in Healthy VolunteersCompletedNCT06361277Phase 1
- To Evaluate the Safety and PK Characteristics in Healthy VolunteersCompletedNCT06355349Phase 1
- A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout PatientsCompletedNCT05815901Phase 3
- To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With T2DMCompletedNCT05814406Phase 3
- To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With Type 2 Diabetes MellitusCompletedNCT05814393Phase 3
- To Evaluate the PK, PD, Safety and Drug Tolerance of JW0302 in Healthy VolunteersCompletedNCT05784155Phase 1
- A Trial to Evaluate the Effect of LEO 152020 on the Heart of Healthy PeopleCompletedNCT05508776Phase 1
- To Evaluate the Pharmacokinetic Drug Interactions, Safety and Drug Tolerance in Healthy VolunteersCompletedNCT05463497Phase 1
- To Evaluate the PK, PD, Safety and Drug Tolerance in Healthy VolunteersCompletedNCT05433844Phase 1
- To Evaluate the Pharmacokinetic Interactions and Safety in Healthy VolunteersCompletedNCT05351840Phase 1
- To Evaluate the Efficacy and Safety in Patients With Dyslipidemia and HypertensionCompletedNCT05331014Phase 3
- A Safety, PK, PD and Food Effect Study of URC102 in Healthy Adults and Patients With Renal ImpairmentCompletedNCT05198778Phase 1
- Registry Study of ID & IDA in Korean Patients With Heart FailureCompletedNCT04812873
- MAGE of Anagliptin Compared With Sitagliptin With Type 2 Diabetes MellitusCompletedNCT04810507Phase 4
- The Safety of Emicizumab SC Injection in Korean Hemophilia A Patients With/Without FVIII InhibitorsStatus unknownNCT04805801
- Study of of URC102 to Assess the Efficacy and Safety in Gout PatientsCompletedNCT04804111Phase 2
- To Evaluate the Efficacy and Safety in Patients With Primary HypercholesterolemiaCompletedNCT04584736Phase 3
- Efficacy and Safety of Pitavastatin in a Real-world SettingCompletedNCT04402112
- The Occurrence of MACE in Patients With AMI Receiving Pitavastatin/Valsartan TreatmentStatus unknownNCT04270344
- Korean Observational Study to Evaluate the Efficacy and Safety of Anagliptin Switching From Other DPP4is in type2 DMStatus unknownNCT04267601
- A Trial to Evaluate the Effect of Food on LEO 152020CompletedNCT04203836Phase 1
- A Study to Evaluate Efficacy and Safety of JTZ-951 Compared to Darbepoetin Alfa in Korean Renal Anemia Patients Receiving Hemodialysis.CompletedNCT04027517Phase 3
- Single and Multiple Ascending Dose Study of JW1601 for Healthy VolunteersCompletedNCT04018170Phase 1
- Clinical Study of CWP232291 in Acute Myeloid Leukemia PatientsTerminatedNCT03055286Phase 1/2
- Study of URC102 to Assess the Safety and Efficacy in Gout PatientsCompletedNCT02557126Phase 2
- Phase 1 Study(Additional) of URC102 in Healthy SubjectsCompletedNCT02524678Phase 1
- Clinical Study of CWP232291 in Relapsed or Refractory Myeloma PatientsCompletedNCT02426723Phase 1
- Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout PatientsCompletedNCT02290210Phase 2
- Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic HyperplasiaCompletedNCT02106182Phase 4
- to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and HyperlipidemiaCompletedNCT02056847Phase 4
- Observational Study to Evaluate Effect of Thrupas® Capsule on Cardiovascular SystemCompletedNCT02029560
- Phase 1 Study of URC102 in Healthy SubjectsCompletedNCT01953497Phase 1
- To Evaluate the Safety and PK Characteristics in Healthy Volunteers-LivalozetCompletedNCT01764178Phase 1
- This Study is to Evaluate the Safety and Efficacy of Avanafil in the Treatment of Erectile Dysfunction.CompletedNCT01705197Phase 3
- Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral StonesCompletedNCT01533389Phase 4
- Efficacy and Safety of CWP-0403 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin AloneCompletedNCT01529541Phase 3
- A Study to Efficacy and Safety of CWP-0403 in Type 2 Diabetes Mellitus PatientsCompletedNCT01529528Phase 3
- Pharmacokinetics of Mitiglinide and Metformin in Free Combination and Fixed-dose Combination in Healthy Male Subjects.CompletedNCT01443221Phase 1
- Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy SubjectsCompletedNCT01406431Phase 1
- Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and DyslipidemiaCompletedNCT01402843Phase 3
- Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia PatientsCompletedNCT01398462Phase 1
- Livalo Acute Myocardial Infarction Study (LAMIS)CompletedNCT01265706
- Safety and Efficacy of QD Versus BID Silodosin With Lower Urinary Tract Symptoms Suggestive of BPHCompletedNCT01260129Phase 4
- Study of a α1A Adrenoceptor Selective Antagonist Silodosin to Treat Severe Benign Prostatic Hyperplasia(BPH)CompletedNCT01259531Phase 4
- To Evaluate 1 Year Extension Study of the Efficacy and Safety of Tocilizumab in Patients With Moderate to Severe Rheumatoid ArthritisCompletedNCT01256736Phase 3
- Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic BladderCompletedNCT01228370Phase 4
- Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid ArthritisCompletedNCT01211834Phase 3
- Efficacy and Safety Study of Pitavastatin Versus Atorvastatin to Treat HypercholesterolemiaCompletedNCT01166633Phase 4
- Study of Erythropoietin (EPO) Administration ScheduleCompletedNCT01111630Phase 4
- Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of AvanafilCompletedNCT00903981Phase 3
- Therapeutic Exploratory Study of CWP-0403CompletedNCT00888719Phase 2
- Livalo Acute Myocardial Infarction StudyCompletedNCT00805714
- Efficacy and Safety Study of Iron Sucrose and Oral Iron Acetyl-transferrin HydroglycerinCompletedNCT00802139Phase 4
- Pitavastatin Pre-Treatment Study in Patient With Elective PCI for Stable Angina Pectoris (PIPA)WithdrawnNCT00786734Phase 4
- South Korean Pitavastatin Heart Failure StudyCompletedNCT00701285Phase 4
- Glufast On Insulin Glargine Trial in Type 2 DMCompletedNCT00663884Phase 4
- Safety and Efficacy Study of Pitavastatin in Patient With a Metabolic SyndromeCompletedNCT00640276Phase 4